Cargando…

Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections

BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the virus responsible for the Coronavirus Disease 2019 (COVID-19) pandemic. The emergence of variants of concern (VOCs) has become one of the most pressing issues in public health. To control VOCs, it is important to know wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurahashi, Yukiya, Sutandhio, Silvia, Furukawa, Koichi, Tjan, Lidya Handayani, Iwata, Sachiyo, Sano, Shigeru, Tohma, Yoshiki, Ohkita, Hiroyuki, Nakamura, Sachiko, Nishimura, Mitsuhiro, Arii, Jun, Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Nishimura, Yoshihiro, Mori, Yasuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907139/ https://www.ncbi.nlm.nih.gov/pubmed/35281007 http://dx.doi.org/10.3389/fimmu.2022.773652

Ejemplares similares

Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan
por: Furukawa, Koichi, et al.
Publicado: (2021)

Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
por: Furukawa, Koichi, et al.
Publicado: (2022)

Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019
por: Tjan, Lidya Handayani, et al.
Publicado: (2021)

The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients
por: Tjan, Lidya Handayani, et al.
Publicado: (2021)

Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants
por: Ishimaru, Hanako, et al.
Publicado: (2023)

Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
por: Ren, Zhenxiao, et al.
Publicado: (2022)

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
por: Sutandhio, Silvia, et al.
Publicado: (2023)

Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan
por: Furukawa, Koichi, et al.
Publicado: (2021)

Diligent Medical Activities of a Publicly Designated Medical Institution for Infectious Diseases Pave the Way for Overcoming COVID-19: A Positive Message to People Working at the Cutting Edge
por: Nagano, Tatsuya, et al.
Publicado: (2020)

Structural basis for the interaction of human herpesvirus 6B tetrameric glycoprotein complex with the cellular receptor, human CD134
por: Nishimura, Mitsuhiro, et al.
Publicado: (2020)

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
por: Sato, Hiroki, et al.
Publicado: (2020)

The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
por: Kiriu, Tatsunori, et al.
Publicado: (2018)

Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
por: Effendi, Wiwin Is, et al.
Publicado: (2019)

Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
por: Kiriu, Tatsunori, et al.
Publicado: (2019)

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
por: Fujii, Masayoshi, et al.
Publicado: (2023)

Yield of tumor samples with a large guide-sheath in endobronchial ultrasound transbronchial biopsy for non-small cell lung cancer: A prospective study
por: Katsurada, Naoko, et al.
Publicado: (2021)

A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
por: Tachihara, Motoko, et al.
Publicado: (2019)

High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma
por: Dokuni, Ryota, et al.
Publicado: (2020)

Cross-sectional study of cholinergic urticaria subtypes and bronchial hyperresponsiveness
por: Katsurada, Naoko, et al.
Publicado: (2022)

Novel cancer therapy targeting microbiome
por: Nagano, Tatsuya, et al.
Publicado: (2019)

Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease
por: Kiriu, Tatsunori, et al.
Publicado: (2017)

Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters
por: Kunimasa, Kei, et al.
Publicado: (2017)

Crucial Role of Extracellular Vesicles in Bronchial Asthma
por: Nagano, Tatsuya, et al.
Publicado: (2019)

Regional Environmental Breadth Predicts Geographic Range and Longevity in Fossil Marine Genera
por: Heim, Noel A., et al.
Publicado: (2011)

Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy
por: Katsurada, Masahiro, et al.
Publicado: (2022)

Tetrameric glycoprotein complex gH/gL/gQ1/gQ2 is a promising vaccine candidate for human herpesvirus 6B
por: Wang, Bochao, et al.
Publicado: (2020)

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
por: Furukawa, Koichi, et al.
Publicado: (2020)

Experimental Evolution Expands the Breadth of Adaptation to an Environmental Gradient Correlated With Genome Reduction
por: Kurokawa, Masaomi, et al.
Publicado: (2022)

Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
por: Miwa, Nanako, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
por: Tea, Fiona, et al.
Publicado: (2021)

The Breadth of Black
Publicado: (1871)

Breadth in contemporary topology
por: Gay, David T, et al.
Publicado: (2019)

AJRCCM: Strength in Breadth
por: Bush, Andrew, et al.
Publicado: (2023)

Longevity Regulation by Proline Oxidation in Yeast
por: Nishimura, Akira, et al.
Publicado: (2021)

Signaling in the phytomicrobiome: breadth and potential
por: Smith, Donald L., et al.
Publicado: (2015)

The Full Breadth of Mendel’s Genetics
por: van Dijk, Peter J., et al.
Publicado: (2016)

The Breadth of Viruses in Human Semen
por: Salam, Alex P., et al.
Publicado: (2017)

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
por: Katsurada, Naoko, et al.
Publicado: (2020)

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
por: Chukwuma, Valentine U., et al.
Publicado: (2018)

Interim Editors Bring Breadth of Experience
por: Korach, Kenneth S.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ofvs9le5pfsho6osdabtps97ra